NASDAQ · Biotechnology · USD

GridAI Technologies Corp. (GRDX) Stock Analysis

GridAI Technologies Corp. (GRDX) is a Biotechnology stock listed on NASDAQ and quoted in US Dollar.

Last Updated: October 21, 2026

GRDX

$4.90

+$0.27 (+5.83%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare GRDX with… →

GRDX Key Statistics

As of Oct 21, 2026

Trading

Open: $4.74
Previous Close: $4.63
Day's Range: 4.72–5.26
52-Week Range: 1.87–6.93
Volume: 77.03K

Valuation

Market Cap: $34.94M
P/E Ratio: unprofitable
EPS (ttm): −5.95

Financials (FY)

Revenue (FY): $36.25K
Net Income (FY): −$6.39M
Shares Outstanding: 7.13M
1-Year Return: +20.69%

Dividend and dates

Avg Volume: 109.75K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, GRDX closed at $4.90, +20.69% over 1 year.

GridAI Technologies Corp. (GRDX) has a market capitalization of $34.94M.

In fiscal 2025, GRDX reported revenue of $36.25K.

GRDX Stock Return by Calendar Year

GridAI Technologies Corp. (GRDX) 10-year return: what $10,000 became

1 year: $10,000 $12,069; +20.69%
5 years: $10,000 $1; −99.99%
10 years: $10,000 $0.08; −99.999%

If you had invested $10,000 in GridAI Technologies Corp. (GRDX) 10 years ago, at the close on October 21, 2016, it would have been worth $0.08 at the close on October 21, 2026: −99.999% in total, −69.15% a year. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

−97.98%+149.73%+5.15%

2016*2017201820192020202120222023202420252026*

Year	Return
2026 (partial year)	+5.15%
2025	+149.73%
2024	−85.19%
2023	−96.58%
2022	−97.98%
2021	−85.10%
2020	−6.73%
2019	−14.05%
2018	−66.73%
2017	−23.27%
2016 (partial year)	−4.82%

As of October 21, 2026.

GRDX Revenue and Earnings by Fiscal Year

FY ends December

RevenueNet income

2022202320242025

Fiscal year	Revenue	Net income	Net margin
2025	$36.25K	−$6.39M	−17,634.4%
2024	$0.00	−$18.06M	—
2023	$0.00	−$15.79M	—
2022	$0.00	−$14.63M	—

Fiscal year	Revenue	Gross profit	Operating income	Net income	Net margin
2025	$36.25K	−$657.43K	−$7.08M	−$6.39M	−17,634.4%
2024	$0.00	$0.00	−$15.62M	−$18.06M	—
2023	$0.00	—	−$15.77M	−$15.79M	—
2022	$0.00	—	−$12.68M	−$14.63M	—

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

Analysis

Data-derived

Company Overview

GridAI Technologies Corp. (GRDX) carries a market capitalisation of $34.94M. It is classified in the Biotechnology industry, within the Healthcare sector.

The 52-week range on file runs from $1.87 to $6.93. GRDX last closed at $4.90 on October 21, 2026. That is +$0.27 (+5.83%) against the previous close. The latest close sits 162.03% above that 52-week low.

Financial Health

The most recent full year on file, fiscal 2025, shows revenue of $36.25K. The same year closed with a net loss of $6.39M. Earnings per share on a trailing basis come to −5.95.

Across the 4 fiscal years on file, revenue moves from $0.00 in 2022 to $36.25K in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published.

Daily returns over the trailing 10 years annualize to a volatility of 118.46%. The trailing one-year total return is +20.69%. Measured over 10 years, that is −69.15% a year compounded.

Growth & Income

The record shows no dividend for GRDX.

The strongest complete calendar year on file is 2025 at +149.73%; the weakest is 2022 at −97.98%. Of the 9 complete calendar years on file, 1 finished higher. 2026 is still running; the total return is +5.15% year to date.

Peer Comparison

GridAI Technologies Corp. (GRDX) operates in the Biotechnology industry. Here is how it compares to its closest peers by market capitalization:

Company	Ticker	Market Cap	P/E Ratio
GridAI Technologies Corp.	GRDX	$34.94M	—
Vertex Pharmaceuticals Incorporated	VRTX	$132.95B	30.4
Moderna, Inc.	MRNA	$98.14B	—
Regeneron Pharmaceuticals, Inc.	REGN	$82.95B	19.9

The Biotechnology industry average P/E ratio is 16.6x. GridAI Technologies Corp. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Biotechnology Stocks

VRTX

Vertex Pharmaceuticals Incorporated

$132.95B

MRNA

Moderna, Inc.

$98.14B

REGN

Regeneron Pharmaceuticals, Inc.

$82.95B

ARGX

argenx SE

$55.97B

ONC

BeOne Medicines AG

$43.97B

RVMD

Revolution Medicines, Inc.

$41.64B

View all Biotechnology stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.13T

JNJ

Johnson & Johnson

$621.22B

ABBV

AbbVie Inc.

$503.27B

UNH

UnitedHealth Group Incorporated

$374.30B

MRK

Merck & Co., Inc.

$369.78B

View all Healthcare stocks →

About GridAI Technologies Corp.

GridAI Technologies Corp., together with its subsidiaries, designs and develops an artificial intelligence (AI)-driven software and device platform that enables utilities, retailers, and large power users to manage load and distributed energy resources. It also develops Adrulipase, a recombinant lipase enzyme program for the treatment of exocrine pancreatic insufficiency. The company is based in Edinburgh, United Kingdom.

Visit website →